OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
August 18, 2016
Fresenius Kabi will add to its generic, sterile injectable manufacturing at its Melrose Park, Illinois site.
August 17, 2016
August 16, 2016
Piramal Enterprises has entered into an agreement to acquire 100% stake in Ash Stevens all by cash for a consideration of $42.95 million plus an earn-out consideration capped at $10 million.
August 15, 2016
Irvine Scientific’s new product range includes chemically-defined, serum-free media, to increase productivity of viral vectors and recombinant proteins in suspension cultures.
The agency has adopted guidelines on the pharmacovigilance of biological drugs.
Jacobs Engineering will provide engineering and construction services to expand the Novartis site in Huningue, France.
August 12, 2016
Zika vaccine development is hindered by technical challenges and funding shortfalls.
Topical semi-solids, like creams, lotions and ointments are comprised of a complex mixture of microstructures or colloidal phases, frequently referred to as the Q3. These microstructures may include micelles, lamellar phases, polymer matrices, liquid crystalline and crystalline states of wax excipients, as well as the solid states of active pharmaceutical ingredients. Different topical medicated semi-solid formulations, spanning a range of treatment indications, reveal a variety of different microstructures.
August 11, 2016
The Claristep filtration system from Sartorius improves preparation of samples for analytical testing.
August 08, 2016
Catalent Pharma Solutions teamed with Zumutor Biologics to develop antibodies with enhanced ADCC activity.